G. S. Kumar et al. / Tetrahedron Letters 54 (2013) 5048–5051
5051
crude products were purified by silica gel column chromatography using ethyl
acetate/hexanes (4:1–1:1). All compounds were characterized by (MP, NMR,
Mass, and IR) spectral data.18
18. Spectral data for new compounds:
4-Bromo-3-ethyl-3-hydroxyindolin-2-one (Table 2, 3f): White solid; Mp 160–
162 °C; 1HNMR (300 MHz, CDCl3 + DMSO-d6):
d 3.68 (s, 1H), 6.98 (d,
J = 8.98 Hz, 1H), 7.26 (d, J = 8.98 Hz, 1H), 7.33–7.42 (m, 5H), 8.02(s, 1H) ppm;
C13 NMR (75 MHz, CDCl3 + DMSO-d6): d 93.3, 109.5, 125.8, 126.1, 126.4, 127.1,
129.3, 129.6, 136.4 139.2, 143.0, 163.0 ppm; IR (KBr):
m = 3374, 3195, 1718,
1611, 1467, 1422, 1303, 1160, 1063, 810, 768, 700 cmꢁ1; MS (EI): m/z = 295
(M+1).
4-Bromo-3-ethyl-3-hydroxyindolin-2-one (Table 2, 3i): White solid; Mp 162–
164 °C; 1HNMR (300 MHz, CDCl3 + DMSO-d6): d 0.59 (t, J = 7.32 Hz, 3H), 1.83 (q,
J = 7.32 Hz, 2H), 5.50 (s, 1H), 6.79 (dd, J = 1.97, 5.93 Hz, 1H), 7.00–7.04 (m, 2H),
10.12 (s, 1H) ppm; C13 NMR (75 MHz, CDCl3 + DMSO-d6): d 4.3, 31.2, 82.1,
113.8, 123.3, 127.3, 128.4, 130.6, 141.8, 177.8 ppm; IR (KBr):
m = 3246, 3177,
1706, 1619, 1472, 1440, 1182, 1082, 930, 826, 730 cmꢁ1; MS (EI): m/z = 279
(M+Na).
3-Ethyl-3-hydroxy-5-(trifluoromethoxy)indolin-2-one (Table 2, 3j): White solid;
Mp 158–160 °C; 1H NMR (300 MHz, CDCl3 + DMSO-d6): d 0.74 (t, J = 7.66 Hz,
3H), 1.92 (q, J = 7.66 Hz, 2H), 5.79 (s, 1H), 6.86 (d, J = 8.20 Hz, 1H), 7.06 (d,
J = 8.20 Hz, 1H), 7.17 (s, 1H), 10.06 (s, 1H) ppm; 13C NMR (75 MHz,
CDCl3 + DMSO-d6):
d 4.3, 31.9, 86.2, 111.1, 111.8, 112.4, 121, 131.8, 133,
156.3, 177.8 ppm; IR (KBr)
m = 3346, 3157, 1709, 1629, 1462, 1240, 1182, 1082,
920, 816 cmꢁ1; MS (EI): m/z = 262 (M+1).
5-Chloro-3-ethyl-3-hydroxyindolin-2-one (Table 2, 3k): White solid; Mp 204-
2060C; 1H NMR (300 MHz, CDCl3+ DMSO-d6): d 0.72 (t, J = 7.32 Hz, 3H), 1.84 (q,
J = 7.32 Hz, 2H), 5.72 (s, 1H), 6.78 (t, J = 8.54 Hz, 1H), 7.12 (d, J = 8.54 Hz, 1H),
7.19 (s, 1H), 10.10 (s, 1H) ppm; 13C NMR (75 MHz, CDCl3+ DMSO-d6): d 4.3,
31.9, 85.4, 110.9, 125.9, 126.3, 126.6, 132.2, 139.0, 177.8 ppm; IR (KBr):
m =
3256, 2942, 1703, 1605, 1490, 1423, 1325, 1185, 1070, 985, 924, 798 cm-1; MS
(ESI): m/z = 234 (M+Na).
17. General procedure: To a solution of isatin 1 (1 mmol) in toluene (5 mL) was
added the solution of trialkyl/aryl Al 2 (2 mmol, 2 M in toluene) dropwise at
RT. Then the mixture was heated at 70 °C and stirred for additional 3–3.5 h (see
Table 2). The reaction was monitored by TLC. After completion of the reaction,
toluene was evaporated and extracted with ethyl acetate (3 ꢀ 5 mL). The
combined organic layer was washed with brine solution, dried over anhydrous
Na2SO4, and concentrated under reduced pressure (rotary evaporator). The
3-Ethyl-3-hydroxy-5-nitroindolin-2-one (Table 2, 3l): White solid; Mp 209–
211 °C; 1H NMR (300 MHz, CDCl3 + DMSO-d6): d 0.76 (d, J = 7.00 Hz, 3H), 1.92
(q, J = 7.00 Hz, 2H), 5.92 (s, 1H), 6.95 (d, J = 8.0 Hz, 1H), 8.09–8.14 (m, 2H), 10.6
(s, 1H); 13C NMR (75 MHz, CDCl3 + DMSO-d6): d 4.3, 31.9, 84.9, 108.9, 121.4,
124.7, 131.7, 143.6, 147, 177.8; IR (KBr):
m = 3285, 2927, 2856, 1714, 1624,
1524, 1338, 1177, 1089, 840, 734 cmꢁ1; MS (EI): m/z = 223 (M+1).
3-Ethyl-3-hydroxy-5-iodoindolin-2-one (Table 2, 3m): White solid; Mp 220–
227 °C; 1H NMR (300 MHz, CDCl3 + DMSO-d6): d 0.71 (t, J = 7.62 Hz, 3H), 1.82 (t,
J = 7.62 Hz, 2H), 5.74 (s, 1H), 6.62 (d, J = 8.71 Hz, 1H), 7.45 (d, J = 7.62 Hz, 1H),
7.49 (s, 1H), 10.14 (s, 1H) ppm; 13C NMR (75 MHz, CDCl3 + DMSO-d6): d 4.3,
31.9, 85., 90.0, 123.3, 132.4, 135.1, 139.2, 139.8, 177.8 ppm; IR (KBr)
m = 3258,
3184, 2920, 1701, 1626, 1489, 1157, 927, 817, 733 cmꢁ1; MS (EI): m/z = 326
(M+Na).
3-Ethyl-5-fluoro-3-hydroxyindolin-2-one (Table 2, 3n): White solid; Mp 158–
160 °C; 1H NMR (300 MHz, CDCl3 + DMSO-d6): d 0.72 (t, J = 7.55 Hz, 3H), 1.90
(q, J = 7.55 Hz, 2H), 5.86 (s, 1H), 6.81 (d, J = 8.30 Hz, 1H), 6.86–6.93 (m, 1H),
7.02 (dd, J = 7.93, 8.30 Hz, 1H), 10.06 (s, 1H) ppm; 13C NMR (75 MHz,
CDCl3 + DMSO-d6): d 6.7, 30.3, 84.4, 110.7, 111.0, 114.1, 132.5, 136.9, 159.5,
179.5 ppm; IR (KBr):
m = 3267, 2933, 1698, 1610, 1485, 1435, 1343, 1175, 1095,
993, 805, 704 cmꢁ1; MS (EI): m/z = 218 (M+Na).
4,5-Dichloro-3-ethyl-3-hydroxyindolin-2-one (Table 2, 3o): Yellow solid; Mp
228–230 °C; 1HNMR (300 MHz, CDCl3 + DMSO-d6): d 0.59 (t, J = 7.00 Hz, 3H),
1.90 (q, J = 7.00 Hz, 2H), 5.79 (s, 1H), 6.73 (d, J = 8.00 Hz, 1H), 7.29 (d,
J = 8.00 Hz, 1H), 10.10 (s, 1H) ppm; 13C NMR (75 MHz, CDCl3 + DMSO-d6): d 4.3,
31.4, 80.3, 109.0, 125.8, 129.1, 129.1, 132.5, 139.1, 177.8 ppm; IR (KBr):
m
= 3256, 2942, 1703, 1605, 1490, 1423, 1325, 1185, 1070, 985, 924, 798 cmꢁ1
;
MS (EI): m/z = 247 (M+1).
3-Hydroxy-5-iodo-3-methylindolin-2-one (Table 2, 3t): Yellow solid; Mp 248–
250 °C; 1HNMR (300 MHz, CDCl3 + DMSO-d6): d 1.48 (s, 3H), 5.82 (s, 1H), 6.67
(d, J = 8.60 Hz, 1H), 7.48 (s, 1H), 7.58 (s, 1H), 10.03 (s, 1H) ppm; 13C NMR
(75 MHz, CDCl3 + DMSO-d6): d 23.2, 77.4, 90.4, 123.7, 129.5, 136.7, 140.7,
141.3, 177.5 ppm; IR (KBr):
m = 3258, 3184, 2920, 1701, 1626, 1489, 1157, 927,
817, 733 cmꢁ1; MS (ESI): m/z = 312 (M+Na).